PaulaNSilvermanMD

Clinical Trials

• Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer Start of enrollment: 2000 Jun 08

  Completed

  Phase 2

• Phase II Bevacizumab + Tax In Advanced Breast Cancer Start of enrollment: 2001 Nov 01

  Completed

  Phase 2

• Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases Start of enrollment: 2002 Nov 01

  Completed

  Phase 1, Phase 2

• Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer Start of enrollment: 2003 Nov 01

  Terminated

  Phase 1

• PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Start of enrollment: 2010 Feb 01

  Completed

  Phase 2

• Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07

  Completed

  Phase 2

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  Active, not recruiting

  Phase 3

• Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer Start of enrollment: 2013 Oct 22

  Active, not recruiting

  Phase 1, Phase 2

• Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01

  Completed

  Phase 2

• Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate Start of enrollment: 2015 Nov 17

  Completed

  Phase 2

• Join now to see all